Market by Animal Type, Disease Type, Product Type, and Country Outlook | Forecast 2022-2028
A study by Triton Market Research on
Europe’s veterinary vaccines market shows that it would develop with a CAGR of 7.06% in the forecast period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market include:
• Germany
• Spain
• France
• Italy
• The
United Kingdom
• Rest
of Europe
Europe is home to a number of globally renowned
veterinary pharmaceutical companies. The presence of such top market players attracts
a large amount of foreign investment into the region, which drives the overall
market here. Further, notable advancements in technology, research &
development, advanced vaccines, innovation, etc., are some of the key factors
that enable and drive the growth of the veterinary vaccines market in the
European region.
While immunizations are recommended for the
overall health of pet animals in Spain, the only vaccine mandated in the
country is the rabies vaccine. The government authorizes rabies vaccination for
dogs, cats, and ferrets every 3 years. Moreover, vaccines for distemper,
parvovirus, and other diseases are also provided to dogs across Spain. Thus,
the regulations & initiatives by the government largely contribute to the
growth of the veterinary vaccines market in the country.
There are nearly 2 million pet dogs and 3
million pet cats in the Netherlands. In addition, the nation boasts of having
one of the biggest livestock sectors in the European region, with more than 100
million cattle, pigs, and hens. It also accounts for the largest meat exports
in the region. With such a vast animal population, vaccination is among the
most effective techniques to tackle animal diseases and promote their health
& welfare.
Canine diseases are the type of diseases that
affect dogs and other related species. Some of the most common canine diseases
are rabies, canine distemper, giardia, parainfluenza, Lyme disease, and so on.
Dogs are owned, adopted, or domesticated widely. The vast dog population makes
a large number of them prone to these diseases. Thus, the market by canine
disease type is an excellent opportunity for manufacturers of veterinary
vaccines.
The
studied report assesses the market’s growth based on animal type, disease type,
and product type. Here,
the disease type segment comprises canine disease, bovine disease, porcine
disease, aquaculture disease, poultry disease, and other disease types.
Leading
companies considered in the veterinary vaccines market include Virbac SA,
Elanco Animal Health Inc, Vaxxinova GmbH, Hipra, Boehringer Ingelheim
International GmbH, and Zoetis Inc.
Boehringer Ingelheim is a healthcare company
focusing on improving the health and quality of life of humans as well as
animals. Its portfolio features over 200 products for cats, dogs, pigs, horses,
poultry, and cattle, and has over 20 R&D facilities in Europe and other
parts of the world. The company’s product, VAXXITEK® HVT+IBD+ILT, is the first
vaccine to offer protection in one shot from Marek’s Disease, Infectious Bursal
Disease Infectious, and Laryngotracheitis. Boehringer Ingelheim was founded in
1855 and is headquartered in Ingelheim am Rhein, Germany.
Key deliverables of the
report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the veterinary
vaccines market revenue growth in Europe and its influence on the parent
market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the Europe
veterinary vaccines market’s growth during the upcoming years
Want to get specific insights? Our
team of analysts can customize this report based on your preferences. Connect
with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
VETERINARY VACCINES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE VETERINARY VACCINES MARKET
2.2. KEY
INSIGHTS
2.2.1. INCREASING
INNOVATION BY MARKET PARTICIPANTS
2.2.2. ADVANCEMENTS
IN VACCINE AND DIAGNOSTIC TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VALUE
CHAIN ANALYSIS
2.6. KEY
BUYING CRITERIA
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. CONTRACTS
& AGREEMENTS
2.9.3. PRODUCT
LAUNCHES
2.9.4. EXPANSIONS
& DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. HIGH
VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES
2.10.2. GOVERNMENT-ORGANIZED
VACCINATION DRIVES
2.10.3. ADVANCED
VACCINE RESEARCH AND DEVELOPMENT
2.11. MARKET
CHALLENGES
2.11.1. LACK
OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS
2.11.2. STRINGENT
RULES AND REGULATIONS PERTAINING TO VACCINE USE
2.12. MARKET
OPPORTUNITIES
2.12.1. GROWING
USE OF VACCINES IN THE EUROPEAN MARKET
2.12.2. RISING
DEMAND FOR COMPANION ANIMALS
3. EUROPE
VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE
3.1. LIVESTOCK
ANIMALS
3.1.1. CATTLE
3.1.2. PIGS
3.1.3. POULTRY
3.1.4. SHEEP
3.1.5. OTHER
LIVESTOCK ANIMALS
3.2. COMPANION
ANIMALS
3.2.1. CANINE
3.2.2. FELINE
3.2.3. EQUINE
3.3. AQUACULTURE
4. EUROPE
VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE
4.1. CANINE
DISEASE
4.2. PORCINE
DISEASE
4.3. BOVINE
DISEASE
4.4. POULTRY
DISEASE
4.5. AQUACULTURE
DISEASE
4.6. OTHER
DISEASE TYPES
5. EUROPE
VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE
5.1. ATTENUATED
VACCINES
5.2. INACTIVATED
VACCINES
5.3. TOXOID
VACCINES
5.4. CONJUGATE
VACCINES
5.5. DNA
VACCINES
5.6. RECOMBINANT
VACCINES
5.7. SUBUNIT
VACCINES
6. EUROPE
VETERINARY VACCINES MARKET – COUNTRY OUTLOOK
6.1. UNITED
KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. SPAIN
6.5. ITALY
6.6. REST
OF EUROPE
7. COMPETITIVE
LANDSCAPE
7.1. BOEHRINGER
INGELHEIM INTERNATIONAL GMBH
7.2. BRILLIANT
BIO PHARMA
7.3. CEVA
SANTE ANIMALE
7.4. ELANCO
ANIMAL HEALTH INC
7.5. HESTER
BIOSCIENCES LTD
7.6. HIPRA
7.7. INDIAN
IMMUNOLOGICALS LIMITED
7.8. MERCK
ANIMAL HEALTH
7.9. PHIBRO
ANIMAL HEALTH
7.10. VAXXINOVA
GMBH
7.11. VIRBAC
SA
7.12. ZOETIS
INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE VETERINARY
VACCINES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: VENDOR SCORECARD
TABLE 4: EUROPE VETERINARY
VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: EUROPE VETERINARY
VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 6: EUROPE VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 7: EUROPE VETERINARY
VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 8: EUROPE VETERINARY
VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: EUROPE VETERINARY
VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: VALUE CHAIN ANALYSIS
FIGURE 3: KEY BUYING CRITERIA
FIGURE 4: EUROPE VETERINARY
VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028 (IN %)
FIGURE 5: EUROPE VETERINARY
VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
FIGURE 6: EUROPE VETERINARY
VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 & 2028 (IN %)
FIGURE 7: EUROPE VETERINARY
VACCINES MARKET, BY CATTLE, 2022-2028 (IN $ MILLION)
FIGURE 8: EUROPE VETERINARY
VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)
FIGURE 9: EUROPE VETERINARY
VACCINES MARKET, BY POULTRY, 2022-2028 (IN $ MILLION)
FIGURE 10: EUROPE VETERINARY
VACCINES MARKET, BY SHEEP, 2022-2028 (IN $ MILLION)
FIGURE 11: EUROPE VETERINARY
VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
FIGURE 12: EUROPE VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
FIGURE 13: EUROPE VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2021 & 2028 (IN %)
FIGURE 14: EUROPE VETERINARY
VACCINES MARKET, BY CANINE, 2022-2028 (IN $ MILLION)
FIGURE 15: EUROPE VETERINARY
VACCINES MARKET, BY FELINE, 2022-2028 (IN $ MILLION)
FIGURE 16: EUROPE VETERINARY
VACCINES MARKET, BY EQUINE, 2022-2028 (IN $ MILLION)
FIGURE 17: EUROPE VETERINARY
VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $ MILLION)
FIGURE 18: EUROPE VETERINARY
VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028 (IN %)
FIGURE 19: EUROPE VETERINARY
VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 20: EUROPE VETERINARY
VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: EUROPE VETERINARY
VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 22: EUROPE VETERINARY
VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 23: EUROPE VETERINARY
VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 24: EUROPE VETERINARY
VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028 (IN $ MILLION)
FIGURE 25: EUROPE VETERINARY
VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 26: EUROPE VETERINARY
VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 27: EUROPE VETERINARY
VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 28: EUROPE VETERINARY
VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 29: EUROPE VETERINARY
VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 30: EUROPE VETERINARY
VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 31: EUROPE VETERINARY
VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 32: EUROPE VETERINARY
VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 33: EUROPE VETERINARY
VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 34: UNITED KINGDOM
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: GERMANY VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: FRANCE VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: SPAIN VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: ITALY VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: REST OF EUROPE
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)